Publication | Closed Access

Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus

Soft-tissue InfectionsMethicillin-resistant Staphylococcus AureusHealth SciencesAntibioticsHealthcare-associated InfectionTopical DrugWound HealingAntimicrobial ChemotherapyInfection ControlDermatologyLinezolid Versus VancomycinMedicineClinical MicrobiologyAntimicrobial ResistanceDrug Resistance